Prolonged overall survival with lenalidomide plus dexamethasone compared with dexamethasone alone in patients with relapsed or refractory multiple myeloma

被引：13
|
作者：
Weber, Donna [1 ]
Knight, Robert [2 ]
Chen, Christine [3 ]
Spencer, Andrew [4 ]
Yu, Zhinuan [2 ]
Zeldis, Jerome [2 ]
Olesnyckyj, Marta [2 ]
Dimopoulos, Meletios [5 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Celgene Corp, Summit, NJ USA
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[5] Univ Athens, Sch Med, GR-11527 Athens, Greece
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.412.412
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
412
引用
收藏
页码：128A / 128A
页数：1
相关论文
共 50 条
  • [21] Comparison of Overall Survival Associated with Lenalidomide plus Dexamethasone and Bortezomib plus Dexamethasone Among Relapsed / Refractory Multiple Myeloma Patients: A Matched Analysis of Real World and Clinical Trial Populations
    Nooka, Ajay
    Voorhees, Peter M.
    Kumar, Shaji K.
    Mehra, Maneesha
    Lam, Annette
    Slavcev, Mary
    Potluri, Ravi
    Dasgupta, Anandaroop
    BLOOD, 2017, 130
  • [22] EXPANDED ACCESS PROGRAM (EAP) FOR LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Palumbo, A.
    Gay, F.
    Buda, G.
    Guglielmelli, T.
    Perrone, G.
    Corradini, P.
    Benedetti, F.
    Offidani, M.
    Rossi, D.
    Gozzetti, A.
    Catalano, L.
    Canepa, L.
    Di Raimondo, F.
    Patriarca, F.
    Petrucci, M. T.
    Di Renzo, N.
    Galli, M.
    Cavallo, F.
    Bringhen, S.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 257 - 257
  • [23] LONGER DURATION OF TREATMENT AND MAINTENANCE OF BEST RESPONSE WITH LENALIDOMIDE plus DEXAMETHASONE INCREASES OVERALL SURVIVAL (OS) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    San Miguel, J.
    Dimopoulos, M.
    Bravo, M. -L.
    Weber, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 382 - 382
  • [24] Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma
    Richter, Joshua R.
    Bilotti, Elizabeth
    McBride, Laura
    Schmidt, Linda
    Gao, Zhijie
    Tufail, Madiha
    Anand, Palka
    McNeill, Ann
    Bednarz, Urszula
    Graef, Thorsten
    Vesole, David H.
    Siegel, David S.
    BLOOD, 2011, 118 (21) : 1706 - 1706
  • [25] Daratumumab Plus Lenalidomide and Dexamethasone (DRd) Compared to Daratumumab Plus Pomalidomide and Dexamethasone (DPd) in Relapsed Lenalidomide-Exposed or Refractory Multiple Myeloma (MM) Patients: The Mayo Clinic Experience
    Moustafa, Muhamad Alhaj
    Parrondo, Ricardo
    Abdulazeez, Mays F.
    Roy, Vivek
    Sher, Taimur
    Alegria, Victoria R.
    Warsame, Rahma M.
    Larsen, Jeremy
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Kapoor, Prashant
    Fonseca, Rafael
    Buadi, Francis K.
    Dingli, David
    Hayman, Suzanne R.
    Reeder, Craig B.
    Agrawal, Arshi
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    BLOOD, 2020, 136
  • [26] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
    Palumbo, Antonio
    Dimopoulos, Meletios
    San Miguel, Jesus
    Harousseau, Jean-Luc
    Attal, Michel
    Hussein, Mohamad
    Knop, Stefan
    Ludwig, Heinz
    von Lilienfeld-Toal, Marie
    Sonneveld, Pieter
    BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
  • [27] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Pareto, A. E.
    Zacheo, I.
    Di Perna, M.
    Nappi, D.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S116 - S117
  • [28] The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
    Bahlis, Nizar J.
    Song, Kevin W.
    Fu, Tommy
    Roland, Birgitte J.
    Chang, Hong
    Horsman, Doug
    Mansoor, Adnan
    Chen, Christine
    Masih-Khan, Esther
    Trieu, Young
    Bruyere, Helene
    Stewart, Douglas A.
    Reece, Donna E.
    BLOOD, 2008, 112 (11) : 610 - 610
  • [29] Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
    Weber, Donna M.
    Chen, Christine
    Niesvizky, Ruben
    Wang, Michael
    Belch, Andrew
    Stadtmauer, Edward A.
    Siegel, David
    Borrello, Ivan
    Rajkumar, S. Vincent
    Chanan-Khan, Asher Alban
    Lonial, Sagar
    Yu, Zhinuan
    Patin, John
    Olesnyckyj, Marta
    Zeldis, Jerome B.
    Knight, Robert D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2133 - 2142
  • [30] Longer Duration of Treatment and Maintenance of Best Response with Lenalidomide and Dexamethasone Prolongs Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma
    Miguel, Jesos F. San
    Dimopoulos, Meletios A.
    Stadtmauer, Edward A.
    Rajkumar, S. Vincent
    Siegel, David
    Bravo, Marie-Laure
    Olesnyckyj, Marta
    Knight, Robert D.
    Zeldis, Jerome B.
    Harousseau, Jean-Luc
    Weber, Donna M.
    BLOOD, 2008, 112 (11) : 1269 - 1269
12345